Literature DB >> 20180076

Primary colorectal signet-ring cell carcinoma: clinicopathological features and postoperative survival.

Tsunekazu Mizushima1, Masaya Nomura, Makoto Fujii, Hiroki Akamatsu, Hitoshi Mizuno, Harumi Tominaga, Junichi Hasegawa, Kiyokazu Nakajima, Keigo Yasumasa, Masato Yoshikawa, Toshirou Nishida.   

Abstract

PURPOSE: The objective of this study was to investigate the clinicopathological features and postoperative survival of primary colorectal signet-ring cell carcinoma.
METHODS: Nineteen patients with primary colorectal signet-ring cell carcinoma were identified from a database of 5884 surgical patients with colorectal cancers treated surgically at Osaka University Hospital and affiliated hospitals between 1993 and 2007. The clinicopathological data of those patients were compared with those of 5792 patients with non-signet-ring cell colorectal carcinoma (5417 with well or moderately differentiated adenocarcinoma and 375 with poorly differentiated adenocarcinoma or mucinous carcinoma).
RESULTS: All patients showed a tumor depth of over T3. Lymph node involvement occurred in 14 patients. Seven of 19 patients presented with distant metastasis at the time of diagnosis. The overall 5-year survival rate in primary signet-ring cell carcinoma was significantly lower at 24.1%, in comparison to 77.5% in well or moderately differentiated adenocarcinoma and 57.7% in poorly differentiated adenocarcinoma or mucinous carcinoma. Likewise, the postoperative survival in Stage III was also significantly worse. On the other hand, no significant difference was observed in Stage II or IV.
CONCLUSION: The most important feature of primary colorectal signet-ring cell carcinoma is the advanced stage at the time of diagnosis. In addition, the postoperative survival is worse than for other types of colorectal cancer.

Entities:  

Mesh:

Year:  2010        PMID: 20180076     DOI: 10.1007/s00595-009-4057-y

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  21 in total

1.  Signet-ring cell carcinoma of the colon and rectum: a matched control study.

Authors:  A Nissan; J G Guillem; P B Paty; W D Wong; A M Cohen
Journal:  Dis Colon Rectum       Date:  1999-09       Impact factor: 4.585

Review 2.  Primary signet-ring cell carcinoma of the colon and rectum: report of eight cases and review of 154 Japanese cases.

Authors:  Tomoki Makino; Toshimasa Tsujinaka; Hideuki Mishima; Masakazu Ikenaga; Toshiro Sawamura; Shoji Nakamori; Kazumasa Fujitani; Motohiro Hirao; Masaki Kashiwazaki; Norikazu Masuda; Masashi Takeda; Masayuki Mano
Journal:  Hepatogastroenterology       Date:  2006 Nov-Dec

3.  FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study.

Authors:  Christophe Tournigand; Thierry André; Emmanuel Achille; Gérard Lledo; Michel Flesh; Dominique Mery-Mignard; Emmanuel Quinaux; Corinne Couteau; Marc Buyse; Gérard Ganem; Bruno Landi; Philippe Colin; Christophe Louvet; Aimery de Gramont
Journal:  J Clin Oncol       Date:  2003-12-02       Impact factor: 44.544

4.  Primary signet ring cell carcinoma of colorectum: an age- and sex-matched controlled study.

Authors:  S Y Tung; C S Wu; P C Chen
Journal:  Am J Gastroenterol       Date:  1996-10       Impact factor: 10.864

5.  Advanced gastric carcinoma with signet ring cell histology.

Authors:  Chen Li; Sungsoo Kim; Ji Fu Lai; Woo Jin Hyung; Won Hyuk Choi; Seung Ho Choi; Sung Hoon Noh
Journal:  Oncology       Date:  2007-11-14       Impact factor: 2.935

6.  Significance of signet-ring cells in patients with colorectal cancer.

Authors:  Rashmi Pande; Annette Sunga; Charles Levea; Gregory E Wilding; Wiam Bshara; Mary Reid; Marwan G Fakih
Journal:  Dis Colon Rectum       Date:  2007-11-21       Impact factor: 4.585

7.  Primary mucinous adenocarcinomas and signet-ring cell carcinomas of colon and rectum.

Authors:  G B Secco; R Fardelli; E Campora; G Lapertosa; R Gentile; S Zoli; C Prior
Journal:  Oncology       Date:  1994 Jan-Feb       Impact factor: 2.935

8.  Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma.

Authors:  C G Moertel; T R Fleming; J S Macdonald; D G Haller; J A Laurie; P J Goodman; J S Ungerleider; W A Emerson; D C Tormey; J H Glick
Journal:  N Engl J Med       Date:  1990-02-08       Impact factor: 91.245

9.  Primary signet-ring carcinoma of the large bowel. Report of nine cases.

Authors:  A Giacchero; H Aste; P Baracchini; M Conio; E Fulcheri; G Lapertosa; R Tanzi
Journal:  Cancer       Date:  1985-12-01       Impact factor: 6.860

10.  Primary signet-ring cell carcinoma of the colon and rectum.

Authors:  T Anthony; R George; M Rodriguez-Bigas; N J Petrelli
Journal:  Ann Surg Oncol       Date:  1996-07       Impact factor: 5.344

View more
  22 in total

1.  The prognostic value of signet ring cell histology in stage I/II colon cancer-a population-based, propensity score-matched analysis.

Authors:  Christoph Jakob Ackermann; Ulrich Guller; Wolfram Jochum; Bruno M Schmied; Rene Warschkow
Journal:  Int J Colorectal Dis       Date:  2018-06-07       Impact factor: 2.571

2.  Goblet cell carcinoid of the rectum with lymph node metastasis: report of a case.

Authors:  Takumi Yamabuki; Makoto Omi; Atsuya Yonemori; Satoshi Hayama; Soichi Murakami; Hitoshi Inomata; Michio Mori; Kazuyoshi Nihei
Journal:  Surg Today       Date:  2011-08-26       Impact factor: 2.549

3.  Clinicopathology and outcomes for mucinous and signet ring colorectal adenocarcinoma: analysis from the National Cancer Data Base.

Authors:  John R Hyngstrom; Chung-Yuan Hu; Yan Xing; Y Nancy You; Barry W Feig; John M Skibber; Miguel A Rodriguez-Bigas; Janice N Cormier; George J Chang
Journal:  Ann Surg Oncol       Date:  2012-04-04       Impact factor: 5.344

4.  Signet ring cell component predicts the response to neoadjuvant chemoradiotherapy in rectal cancer. Long interim results of a single institution experience.

Authors:  Alia M Attia; Ashraf Farrag; Noha M Attia; Lamiaa Mr Khalaf; Hesham M Hassan; Mahmoud Gamal Ameen; Ebrahim Aboeleuon; Sanaa Saber Abd El-Raheem; Ahmed Mahran; Ahmed Mubarak Hefni
Journal:  Am J Cancer Res       Date:  2022-03-15       Impact factor: 6.166

5.  Colorectal Cancer Prognosis: The Impact of Signet Ring Cell.

Authors:  Refik Bademci; Jesus Bollo; M Carmen Martinez; Maria Pilar Hernadez; Eduardo Maria Targarona
Journal:  Gastrointest Tumors       Date:  2019-07-31

6.  The Predictive and Guidance Value of Signet Ring Cell Histology for Stage II/III Colon Cancer Response to Chemotherapy.

Authors:  Huici Jiang; Dongxuan Shao; Peiyu Zhao; Yupeng Wu
Journal:  Front Oncol       Date:  2021-02-23       Impact factor: 6.244

7.  A minor (<50%) signet-ring cell component associated with poor prognosis in colorectal cancer patients: a 26-year retrospective study in China.

Authors:  Yinuo Tan; Jianfei Fu; Xiaofen Li; Jiao Yang; Mengjie Jiang; Kefeng Ding; Jinghong Xu; Jun Li; Ying Yuan
Journal:  PLoS One       Date:  2015-03-19       Impact factor: 3.240

8.  Clinicopathologic and Molecular Features of Colorectal Adenocarcinoma with Signet-Ring Cell Component.

Authors:  Qing Wei; Xicheng Wang; Jing Gao; Jian Li; Jie Li; Changsong Qi; Yanyan Li; Zhongwu Li; Lin Shen
Journal:  PLoS One       Date:  2016-06-14       Impact factor: 3.240

9.  Clinical Features and Prognosis of Resectable Primary Colorectal Signet-Ring Cell Carcinoma.

Authors:  Ho-Su Lee; Jae Seung Soh; Seohyun Lee; Jung Ho Bae; Kyung-Jo Kim; Byong Duk Ye; Jeong-Sik Byeon; Seung-Jae Myung; Suk-Kyun Yang; Sun A Kim; Young Soo Park; Seok-Byung Lim; Jin Cheon Kim; Chang Sik Yu; Dong-Hoon Yang
Journal:  Intest Res       Date:  2015-10-15

10.  Prognostic Impact of Microsatellite Instability in Colorectal Cancer Presenting With Mucinous, Signet-Ring, and Poorly Differentiated Cells.

Authors:  Sang Hun Jung; So Hyun Kim; Jae Hwang Kim
Journal:  Ann Coloproctol       Date:  2016-04-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.